# Mesh Bio Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mesh-bio-pte

- Industry: Healthcare IT
- Headquarters: Singapore
- Website: www.meshbio.com
- Total disclosed funding: $7.1M
- Latest round: Series A (Mar 25, 2024)
- Investors on record: 7

## About

Founded in 2018 by Andrew Wu, Arsen Batagov, and Melvin Heng, and based in Singapore, Mesh Bio Pte. Ltd. is a digital healthtech startup that offers a Health Intelligence Platform designed to improve patient care through systems biology and predictive analytics. The firm’s partners include Enterprise Singapore, Block71, Elev8.VC, and Startup Creasphere. In January 2024, Mesh Bio Pte. Ltd. raised Series A funding led by East Ventures, with participation from other investors elev8.vc and SEEDS Capital.

The firm provides clinical decision support and intervention guidance, leveraging AI analytics and scientific data. Mesh Bio's solutions aid healthcare providers in transforming health screening and chronic disease management, facilitating digital transformation via clinical workflow automation and predictive analytics. They enhance patient engagement by offering personalized health insights and risk predictions. Additionally, Mesh Bio supports pharmaceutical development by uncovering pharmacodynamics and identifying novel therapeutic interventions. Their focus includes managing chronic diseases such as cardiovascular conditions, hypertension, diabetes, fatty liver, kidney disease, myocardial infarction, and stroke.

The company intends to use the January 2024 funding to offer its technologies to healthcare providers and expand the deployment of these solutions across Hong Kong and Southeast Asia, mainly Indonesia and the Philippines.

## Funding rounds

- Series A, Mar 25, 2024, $4.5M — SEEDS Capital, East Ventures
- Series A, Oct 12, 2023 — East Ventures
- Seed, Mar 10, 2022, $2.2M — YL Ventures, TAEL Partners, Citrine Capital Management, SEEDS Capital, elev8.vc, Selvedge Venture
- Seed, Apr 26, 2019, $0.4M — TAEL Partners, Citrine Capital Management, SEEDS Capital, elev8.vc

## Investors

- TAEL Partners (https://capitalatlas.ai/funds/tael-partners) — Seed
- Citrine Capital Management — Seed
- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Seed, Series A
- elev8.vc (https://capitalatlas.ai/funds/elev8-vc) — Seed
- YL Ventures (https://capitalatlas.ai/funds/yl-ventures) — Seed
- Selvedge Venture (https://capitalatlas.ai/funds/selvedge-venture) — Seed
- East Ventures (https://capitalatlas.ai/funds/east-ventures) — Series A